BeOne Medicines (ONC) Gross Profit Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 7.16% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 4.34% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 51.16% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 54.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.36% |
| Dec 31, 2025 | 64.14% |
| Sep 30, 2025 | 57.52% |
| Jun 30, 2025 | 62.05% |
| Mar 31, 2025 | 58.01% |
| Dec 31, 2024 | 80.15% |
| Sep 30, 2024 | 73.54% |
| Jun 30, 2024 | 90.89% |
| Mar 31, 2024 | 3.02% |
| Dec 31, 2023 | 88.42% |
| Sep 30, 2023 | 113.94% |
| Jun 30, 2023 | 113.47% |
| Mar 31, 2023 | 112.94% |
| Dec 31, 2022 | 98.99% |
| Sep 30, 2022 | 117.98% |
| Jun 30, 2022 | 26.95% |
| Mar 31, 2022 | 56.84% |
| Dec 31, 2021 | 49.53% |
| Sep 30, 2021 | 51.76% |
| Jun 30, 2021 | 34.69% |
| Mar 31, 2021 | 173.58% |
| Dec 31, 2020 | 73.45% |
| Sep 30, 2020 | -31.56% |